Adjuvant toremifene versus anastrozole in postmenopausal women with estrogen receptor-positive breast cancer: effects on the serum lipid profile and bone metabolism

Trial Profile

Adjuvant toremifene versus anastrozole in postmenopausal women with estrogen receptor-positive breast cancer: effects on the serum lipid profile and bone metabolism

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Aug 2011

At a glance

  • Drugs Anastrozole (Primary) ; Toremifene (Primary)
  • Indications Early breast cancer
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 01 Aug 2011 Results published in Breast Cancer Research and Treatment.
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top